Severe and disabling constipation: an adverse effect of pregabalin.
The incidence of constipation as an adverse effect of pregabalin has previously been reported as low, with all cases described as either mild or moderate. From the experience of a tertiary referral epilepsy hospital center, we report several cases of severe and disabling constipation after initiating pregabalin, and resolving only on drug withdrawal. Of 80 consecutive patients, six (7.5%) developed significant constipation within 1-2 weeks of commencing pregabalin. Constipation was the most frequent adverse effect that required pregabalin to be withdrawn (6.3% of patients). The severity of symptoms was dose dependent. Pregabalin can cause marked constipation in some patients, and can lead to multiple unnecessary investigations and procedures if the clinician is not aware of this entirely reversible side effect.
The Department of Neurology & Neurological Research, The Department of Medicine, St Vincent's Hospital Melbourne, Melbourne, Vic, Australia. jordan.kamel@svhm.org.au
Jordan T
JT
Kamel
Wendyl J
WJ
D'Souza
Mark J
MJ
Cook
D000328:Adult; D000553:Ambulatory Care / Q000639:trends; D003248:Constipation / Q000139:chemically induced* / Q000175:diagnosis* / Q000503:physiopathology; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement / Q000379:methods; D000069583:Pregabalin; D012720:Severity of Illness Index; D055815:Young Adult; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid